Sivextro Nabriva 01
Sivextro
Product Images NDC 72000-310
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sivextro (NDC 72000-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nabriva Therapeutics Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Sivextro Nabriva 02
This is a description of a medication in tablet form with a usual dosage of 200mg orally once daily. The tablet contains tetizolidphosphate and is manufactured for Nabriva Therapeutics US, Inc. The packaging includes an NDC code and information on the encoding area reserved for serialization barcode, GTIN, serial number, expiry, and lot. The medication is USP controlled at room temperature and was formulated in Canada.*
Sivextro Nabriva 03
This is a label of medicine, "Sivextro" which contains tedizolid phosphate. It comes in 6 tablets with each having 200 mg per tablet. It needs a prescription. The text also includes some medical codes and instructions for use.*
Sivextro Nabriva 04
This is a description of Sivextro® SRR DI e 200mg injection for intravenous infusion. The vial contains inactive ingredients such as mannitol, sodium, and other substances. There is a reserved space for encoding the 2D Serialization Barcode, GTIN, Serial Number, Expiry, and Lot. The product is to be stored in a Rxonly sterile environment at temperatures between 20-25°C or 15°C to 46°C. It is not compatible with nd complce normtion oG Sionscoea Snd ampisrtion.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
